Results 191 to 200 of about 15,040 (247)

Intermittent MDMA Attenuates Ovariectomy-induced Bone Loss via a Gut Microbiota-Bone Axis. [PDF]

Clin Psychopharmacol Neurosci
Wan X, Eguchi A, Murayama R, Mori C, Hashimoto K.   +4 more
europepmc   +1 more source

History, pharmacology and therapeutic mechanisms of 3,4-methylenedioxymethamphetamine (MDMA). [PDF]

Br J Pharmacol
Casey AB, Heifets BD.
europepmc   +1 more source

Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians. [PDF]

Ther Adv Psychopharmacol
Beichmann K, Catzeflis P, Aicher HD, Seragnoli F, Calder A, Amrani A, Hasler G.   +6 more
europepmc   +1 more source

Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review. [PDF]

Cureus
Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J.   +9 more
europepmc   +1 more source

Serotonin modulates nucleus accumbens circuits to suppress aggression in mice. [PDF]

Nat Commun
Zhang Z, Touponse GC, Alderman PJ, Yassine T, Pomrenze MB, Harris TW, Shank AN, Malenka RC, Eshel N.   +8 more
europepmc   +1 more source

Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects. [PDF]

Neuropsychopharmacology
Ertl N, Ashraf I, Azizi L, Roseman L, Erritzoe D, Nutt DJ, Carhart-Harris RL, Wall MB.   +7 more
europepmc   +1 more source

Interpretive Reference Ranges for Plasma Drug Concentrations in Acute Recreational Drug Toxicity: A Short Communication. [PDF]

Ther Drug Monit
Boccuzzi S, Battal D, Cowan D, Dargan PI, Abbate V.   +4 more
europepmc   +1 more source

Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination [PDF]

International Journal of Neuropsychopharmacology, 2014
Methylphenidate and 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') are widely misused psychoactive drugs. Methylphenidate increases brain dopamine and norepinephrine levels by blocking the presynaptic reuptake transporters.
Cedric M Hýsek, Linda D Simmler, Nicole Meyer   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Immunomodulating Activity of MDMA

Annals of the New York Academy of Sciences, 2000
AbstractMDMA (3,4‐methylenedioxymethamphetamine) use can cause neurochemical, behavioral and endocrine alterations, similar to those produced by exposure to acute stress, suggesting its potential as a “chemical stressor.” It is known that stressful stimuli can produce a depression of immune function and an alteration in immune cells distribution.In ...
R, Pacifici, P, Zuccaro, M, Farré, S, Pichini, S, Di Carlo, P N, Roset, C H, Lopez, J, Ortuño, J, Segura, J, Camí, R, de la Torre   +10 more
openaire   +2 more sources

Increased responsiveness to MDMA in adult rats treated neonatally with MDMA

Neurotoxicology and Teratology, 2006
MDMA [(+/-)3,4-methylenedioxymethamphetamine, also known as ecstasy] is a popular recreational drug among women of reproductive age. The objective of this study was to investigate the long-term neurobehavioral consequences of early developmental MDMA exposure. On postnatal days (PD) 1-4, Sprague-Dawley rats received two 10 mg/kg injections of MDMA with
Brian J, Piper, Jerrold S, Meyer
openaire   +2 more sources